Asset Impairment, Restructuring, and Other Special Charges

6 Months Ended

Jun. 30, 2020

Restructuring and Related Activities [Abstract]

Asset Impairment, Restructuring, and Other Special Charges

Asset Impairment, Restructuring, and Other Special Charges

The components of the charges included in asset impairment, restructuring, and other special charges in our consolidated condensed statements of operations are described below.

	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
Severance	$	—	$	—	$	9.8	$	(3.6)
Asset impairment and other special charges	—		—		50.1		427.5
Total asset impairment, restructuring, and other special charges	$	—	$	—	$	59.9	$	423.9

Asset impairment, restructuring, and other special charges recognized during the six months ended June 30, 2020 were primarily related to acquisition and integration costs as part of the closing of the acquisition of Dermira.

Asset impairment and other special charges recognized during the six months ended June 30, 2019 consisted of $400.7 million related to the acquisition of Loxo, substantially all of which was associated with the accelerated vesting of Loxo employee equity awards.